Related Experiment Video
Updated: May 28, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
The Chemopreventive Effect of Ginsenoside Compound K Is Regulated by PARP-1 Hyperactivation, Which Is Promoted by
Sang-Hun Kim1, Sung-Hwan Ki2, Seok-Woo Hyeong3
1Department of Anesthesiology and Pain Medicine, School of Medicine, Chosun University, 309 Pilmundaero, Dong-gu, Gwangju 61452, Republic of Korea.
Background And Aims:
Ginsenoside compound K (CK), a saponin metabolite of ginseng, exerts anticancer effects; however, its molecular mechanisms of action in lung cancer remain unclear. We investigated the involvement of silent information regulator 6 (SIRT6) and poly (ADP-ribose) polymerase 1 (PARP-1) in the anticancer effects of CK in lung cancer.
Methods And Results:
CK induced PARP-1 activation-mediated parthanatos via sequestosome-1/p62-mediated SIRT6 degradation and inhibited the proliferation of H460 cells. Although CK reduced procaspase-8 levels, no significant apoptotic cleavage of procaspase-3 or PARP-1 was observed. Furthermore, CK upregulated p27, p21, phospho-p53, and gamma-H2AX levels. CK increased LC3-II levels in a p62-independent manner, but p62 was upregulated by autophagy inhibition, indicating that p62 is involved in CK-induced autophagy. CK-treated cells showed typical features of parthanatos, including PARP-1 hyperactivation, intracellular redistribution of poly ADP-ribose and pro-apoptotic factors, and chromatin fragmentation. SIRT6 was degraded in a CK concentration- and time-dependent manner. SIRT6 protein was upregulated by PARP-1 inhibition, nicotinamide adenine dinucleotide (NAD)+ supplementation, antioxidants, and p62 knockdown, but was decreased by autophagy blockade. PARP-1 activation was negatively correlated with SIRT6 levels, indicating that SIRT6 and PARP-1 activation play complementary roles in CK-induced growth inhibition. Immunofluorescence staining, fractionation studies, and immunoprecipitation were used to confirm the colocalization and interaction between p62 and SIRT6.
Conclusions:
PARP-1 activation is promoted by p62-mediated SIRT6 degradation, which plays an important role in CK-induced growth inhibition. Therefore, SIRT6 is a potential biomarker for the chemopreventive effect of CK in lung cancer cells, but further studies on SIRT6 are needed for the clinical application of CK.
Insights
Ginsenoside compound K (CK) triggers cancer cell death via PARP-1 activation and SIRT6 degradation in lung cancer. This study reveals CK’s anticancer mechanism, highlighting SIRT6 as a potential biomarker for its chemopreventive effects.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Ginsenoside compound K (CK), a ginseng metabolite, shows anticancer potential.
- The precise molecular mechanisms of CK's action in lung cancer are not fully understood.
- Investigating the roles of silent information regulator 6 (SIRT6) and poly (ADP-ribose) polymerase 1 (PARP-1) in CK's effects is crucial.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the anticancer effects of ginsenoside compound K (CK) in lung cancer.
- To investigate the involvement of silent information regulator 6 (SIRT6) and poly (ADP-ribose) polymerase 1 (PARP-1) in CK-induced lung cancer cell death.
- To determine if SIRT6 can serve as a biomarker for CK's chemopreventive efficacy.
Main Methods:
- Cell proliferation assays were performed on H460 lung cancer cells treated with CK.
- Western blotting, immunofluorescence, and immunoprecipitation were used to analyze protein levels and interactions.
- Levels of SIRT6, PARP-1, p62, and apoptosis markers were assessed.
- Autophagy markers (LC3-II) and DNA damage markers (gamma-H2AX) were evaluated.
Main Results:
- CK induced PARP-1 activation and parthanatos, a form of programmed cell death, through SIRT6 degradation mediated by sequestosome-1/p62.
- CK inhibited H460 cell proliferation and upregulated DNA damage and cell cycle arrest markers (p27, p21, phospho-p53, gamma-H2AX).
- PARP-1 activation was inversely correlated with SIRT6 levels, suggesting complementary roles in CK's anti-proliferative effects.
Conclusions:
- PARP-1 activation, promoted by p62-mediated SIRT6 degradation, is a key mechanism in CK-induced growth inhibition of lung cancer cells.
- SIRT6 degradation plays a critical role in CK's anticancer activity.
- SIRT6 emerges as a potential biomarker for the chemopreventive effects of CK in lung cancer, warranting further clinical investigation.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Negative Regulator Molecules
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCR Desensitization

